US Patent Issued to ETABLISSEMENT FRANCAIS DU SANG, INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON, UNIVERSITE DE FRANCHE-COMTE on Oct. 27 for "CAR-T cells targeting IL-1RAP and their use in acute myeloid leukemia (AML)" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,339, issued on Oct. 27, was assigned to ETABLISSEMENT FRANCAIS DU SANG (La Plaine Saint-Denis Cedex, France), INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (INSERM) (Paris), CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON (Besancon, France) and UNIVERSITE DE FRANCHE-COMTE (Besancon, France).

"CAR-T cells targeting IL-1RAP and their use in acute myeloid leukemia (AML)" was invented by Marina Deschamps (Antorpe, France), Christophe Ferrand (Dampierre, France), Fabrice Larosa (Velars sur Ouche, France) and Walid Warda (Besancon, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is relative to a cell comprising a nucle...